Cargando…
Performance of Male Condoms When Used With and Without a Silicone Placebo Vaginal Ring—A Randomized, Crossover Trial
The dapivirine vaginal ring reduced the risk of HIV infection by approximately 30% in Phase III trials. To ensure higher levels of protection against HIV and sexually transmitted infections, women should be counseled to use condoms when using the vaginal ring. This article evaluates the compatibilit...
Autores principales: | Nel, Annalene, Malherbe, Mariëtte, van Niekerk, Neliëtte, Beksinska, Mags, Greener, Ross, Smit, Jennifer, Frezieres, Ron, Walsh, Terri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417015/ https://www.ncbi.nlm.nih.gov/pubmed/32452969 http://dx.doi.org/10.1097/QAI.0000000000002397 |
Ejemplares similares
-
Performance and Acceptability of the FC2 Female Condom When Used With and Without a Silicone Placebo Vaginal Ring—A Randomized, Crossover Trial
por: Nel, Annalene, et al.
Publicado: (2020) -
Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial
por: Nel, Annaléne, et al.
Publicado: (2018) -
Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence
por: Spence, Patrick, et al.
Publicado: (2016) -
HIV Incidence Remains High in KwaZulu-Natal, South Africa: Evidence from Three Districts
por: Nel, Annaléne, et al.
Publicado: (2012) -
Female condom color and scent preference in Durban, South Africa
por: Beksinska, Mags, et al.
Publicado: (2023)